Table 1.
Patients’ characteristics, with and without infection
| No infection (N = 27) | Infection (N = 14) | p value | |
|---|---|---|---|
| PICU length of stay (days) | 7.7 (IQR 3–19) | 24.1 (IQR 14.9–36.9) | 0.002 |
| VA-ECMO run length (days) | 3.1 (IQR 1.9–6.3) | 6.6 (IQR 4.5–9.4) | 0.009 |
| Age at VA-ECMO (months) | 41.2 (IQR 12.9–81.8) | 40.3 (IQR 9.8–112.9) | 0.62 |
| Weight (kg) | 12 (IQR 7.2–20) | 11 (IQR 5.7–26.8) | 0.84 |
| Hospitalized in PICU at VA-ECMO | 11 (40,7) | 6 (42,9) | 0,9 |
| VA-ECMO inserted in the OR | 18 (66.7) | 7 (50) | |
| VA-ECMO inserted in the ER | 2 (7.4) | 1 (7,1) | |
| VA-ECMO inserted in the PICU | 7 (25.9) | 6 (42,9) | 0,6 |
| Central VA-ECMO | 21 (77.8) | 12 (85.7) | |
| Peripheral VA-ECMO | 4 (14.8) | 2 (14.3) | |
| Peripheral converted to central | 2 (7.4) | 0(0) | 0,8 |
| Leucocytes (G/L)a | 9.9 (IQR 5.7–13.6) | 10.6 (IQR 8.2–13.3) | 0.51 |
| Platelets (G/L)a | 69 (IQR 35–133) | 74 (IQR 69–133) | 0.45 |
| CRP (mg/L)a | 10 (IQR 10–33.5) | 18 (IQR 10–76) | 0.29 |
| Blood glucose (mmol/L)a | 7.8 (IQR 5.1–14.6) | 9.8 (IQR 6.8–14.6) | 0.37 |
| Deceased | 15 (55%) | 7 (50%) | 0.75 |
Data are No. (%) of patients or median (interquartile range, IQR)
aat day 1 of VA-ECMO support
VA-ECMO veno-arterial extracorporeal membrane oxygenation, PICU pediatric intensive care unit